Pyridinyl Imidazole Inhibitor SB203580 Activates p44/42 Mitogen-Activated Protein Kinase and Induces the Differentiation of Human Myeloid Leukemia Cells
Activation of c-Jun N-Terminal Kinase (JNK) by Widely Used Specific p38 MAPK Inhibitors SB202190 and SB203580: A MLK-3-MKK7-Dependent Mechanism
Selectivity of SB203580, SB202190 and Other Commonly Used p38 Inhibitors: Profiling Against a Multi-Enzyme Panel
SB203580 Increases G-CSF Production via a Stem-Loop Destabilizing Element in the 3’ Untranslated Region in Macrophages Independently of Its Effect on p38 MAPK Activity
